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Abstract
Pesticides used in agriculture are designed to protect crops against unwanted species, such as
weeds, insects, and fungus. Many compounds target the nervous system of insect pests. Because of
the similarity in brain biochemistry, such pesticides may also be neurotoxic to humans. Concerns
have been raised that the developing brain may be particularly vulnerable to adverse effects of
neurotoxic pesticides. Current requirements for safety testing do not include developmental
neurotoxicity. We therefore undertook a systematic evaluation of published evidence on
neurotoxicity of pesticides in current use, with specific emphasis on risks during early development.
Epidemiologic studies show associations with neurodevelopmental deficits, but mainly deal with
mixed exposures to pesticides. Laboratory experimental studies using model compounds suggest
that many pesticides currently used in Europe – including organophosphates, carbamates,
pyrethroids, ethylenebisdithiocarbamates, and chlorophenoxy herbicides – can cause
neurodevelopmental toxicity. Adverse effects on brain development can be severe and irreversible.
Prevention should therefore be a public health priority. The occurrence of residues in food and
other types of human exposures should be prevented with regard to the pesticide groups that are
known to be neurotoxic. For other substances, given their widespread use and the unique
vulnerability of the developing brain, the general lack of data on developmental neurotoxicity calls
for investment in targeted research. While awaiting more definite evidence, existing uncertainties
should be considered in light of the need for precautionary action to protect brain development.
Introduction
Pesticides are used widely in agriculture to maintain and
increase crop yields, and they are also applied in homes
and gardens. The annual application of synthetic pesti-
cides to food crops in the EU exceeds 140,000 tonnes [1],
an amount that corresponds to 280 grams per EU citizen
per year. Despite European policies to reduce pesticide
use, EU statistics data for 1992–2003 show that the
annual pesticide consumption has not decreased [1]. A
few hundred different compounds are authorised for use
in all EU member states, but a similar number of pesti-
cides is in current use in different EU countries and are
being evaluated for possible authorisation in all of EU.
Approximately 300 different pesticides have been
reported as contaminants of food products of European
origin [2]. Up to 50 percent of fruits, vegetables and cere-
als grown in the European Union are known to contain
pesticide residues [2], but only a small fraction of pesti-
cides in current use are included in the monitoring pro-
grammes. Nonetheless, one out of twenty food items is
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known to exceed a current EU legal limit for an individual
pesticide [2]. Further, over 25% of fruits, vegetables, and
cereals contain detectable residues of at least two pesti-
cides [2]. Processed food and baby food are also com-
monly contaminated. In addition, other sources, such as
contaminated drinking water, dusts and spray drift con-
tribute to human exposures.
The total level of population exposures to pesticides in
Europe is unknown, but data from US population studies
show that the majority of the population has detectable
concentrations of methyl phosphate, ethyl phosphate,
and other pesticide metabolites in the urine [3].
Many pesticides target the nervous system of insect pests.
Because of the similarity of neurochemical processes,
these compounds are also likely to be neurotoxic to
humans. This concern is of particular relevance to the
developing human brain, which is inherently much more
vulnerable to injury caused by toxic agents than the brain
of adults [4]. During prenatal life, the human brain must
develop from the ectodermal cells of the embryo into a
complex organ consisting of billions of precisely located,
highly interconnected, and specialised cells. For optimum
brain development neurons must move along precise
pathways from their points of origin to their assigned
locations, they must establish connections with other
cells, and they must learn to communicate with other cells
via these connections [4-6]. All of these processes have to
take place within a tightly controlled time frame, and each
developmental stage has to be reached on schedule and in
the correct sequence. If a developmental process in the
brain is halted or inhibited, there is little potential for later
repair, and the consequences may therefore be permanent
[4,6].
Concerns in regard to developmental neurotoxicity due to
pesticides have been fuelled by recent epidemiologic
observations that children exposed prenatally or during
early postnatal life suffer from various neurological defi-
cits [7-12]. Urinary pesticide metabolite concentrations
associated with adverse effects overlap with the ranges
that occur in the general population [3]. Although the
identity of the parent pesticides and the exact magnitude
of causative exposures are unclear, these observations sug-
gest that developmental neurotoxicity from pesticide
exposure is a public health concern.
Despite the increasing recognition of the need to evaluate
developmental neurotoxicity in safety assessment [13-
15], only very few of the commercial chemicals in current
use have been examined with respect to neurodevelop-
mental effects [16]. Validated rodent models exist, but
they are considered expensive and are only infrequently
used. According to the current EU Plant Protection Direc-
tive (91-414-EEC), a neurotoxicity test in hens is required
only for organophosphates and some carbamates to assess
the possible risk of delayed peripheral neurotoxicity fol-
lowing acute exposure.
From a public health viewpoint, the prevention of neu-
rodevelopmental disorders is a priority; these disorders
include learning disabilities, attention deficit hyperactiv-
ity disorder (ADHD), autism spectrum disorders, devel-
opmental delays, and emotional and behavioural
problems. The causes of these disorders are unclear, and
interacting genetic, environmental, and social factors are
likely determinants of abnormal brain development [17].
Medical statistics data are difficult to compare between
countries, but one report suggests that 17% of US children
under18 years of age suffer from a developmental disabil-
ity, in most cases affecting the nervous system [18]. In cal-
culations of environmental burdens of disease in
children, lead neurotoxicity to the developing brain is a
major contributor [19]. Pesticide effects could well be of
the same magnitude, or larger, depending on the exposure
levels.
A recent review [16] listed 201 chemicals known to be
neurotoxic in humans; only 5 of these substances have
been firmly documented as causes of developmental neu-
rotoxicity. Identification of human neurotoxicity was
based on available evidence, including poisoning inci-
dents described in the scientific literature, as identified
from the Hazardous Substances Data Bank of the U.S.
National Library of Medicine. Although published clinical
information may not be representative for the relative
neurotoxicity risks due to industrial chemicals, it is note-
worthy that a total of 90 (45%) of the neurotoxic sub-
stances are pesticides. For these substances, only
neurotoxicity in adults had been documented, thereby
documenting that access to the brain is possible and may
cause toxic effects. Given the vulnerability of the develop-
ing brain, it is likely that many of these substances will
also be capable of causing developmental neurotoxicity
[16]. Indeed, studies in laboratory animals support the
notion that a wide range of industrial chemicals can cause
developmental neurotoxicity even at low doses that are
not harmful to mature animals [14,20].
Given the likely importance of pesticides in regard to
developmental neurotoxicity in humans, this review
focuses on pesticides approved for current use in Europe,
i.e. either authorised or being evaluated for authorisation
within the European Union (Table 1). Our literature
search was conducted by similar means as the previous
review mentioned above [16], but included relevant data
from laboratory experiments. The pesticides are grouped
in accordance with the likely mechanism of action or
chemical similarity. We focus on substances with a pri-
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mary application as pesticides and therefore exclude sub-
stances like nicotine, warfarin, and ethanol with other
primary uses.
Search strategy and selection
We first identified pesticides that have caused neurotoxic
effects in humans from the Hazardous Substances Data
Bank (HSDB) of the U.S. National Library of Medicine
[16]. We searched for the terms "pesticide" and "neuro*".
From the list of substances obtained in this way, we iden-
tified the pesticides, for which neurotoxic effects in
humans had been reported. In addition, we searched the
U.S. National Institute of Occupational Safety and Health
(NIOSH) – Pocket Guide to Chemical Hazards http://
www.cdc.gov/Niosh/npg/npgsyn-p.html, using the search
terms "pesticide", "insecticide", "herbicide", "fungicide",
"fumigant", and "rodenticide" in combination with "cen-
tral nervous system". The list of neurotoxic pesticides
identified in this way was then compared to the current
Annex 1 list (as of August, 2008) of pesticides authorised
in the European Union according to Plant Protection
Directive 91-414-EEC (an Excel data sheet with the status
of active substances under EU review can be downloaded
from http://ec.europa.eu/food/plant/protection/pesti
cides/index_en.print.htm). We chose pesticides with an
Annex 1 status "in" or "pending" for consideration (Table
1).
For each neurotoxic pesticide in current use, we searched
PubMed to identify published data on developmental
Table 1: Neurotoxic pesticides, which are authorised or pending evaluation for authorisation in the EU
Pesticide Annex 1 status
Organophosphate insecticides
Chlorpyrifos In
Dimethoate In
Ethoprophos In
Phosmet In
Fenamiphos (nematicide) In
Carbamates
Pirimicarb In
Methomyl Application resubmitted
Pyrethroid insecticides
Cypermethrin (type II) In
Deltamethrin (type II) In
Pyrethrum/pyrethrin (natural pyrethrin) Pending
Other insecticides
Nicotine Pending
Dithiocarbamate fungicides
Maneb In
Thiram In
Chlorophenoxy herbicides
2,4-D In
Bipyridyl herbicides
Diquat dibromide In
Rodenticides
Warfarin In
Fumigants
Phosphides (zinc, magnesium, and aluminum phosphides) Pending
Sulfuryl fluoride Pending
The list includes pesticicides, which are registered as "in" or "pending" on the current EU Annex 1 list (as of August 2008), and for which 
neurotoxicity in humans has been reported in The Hazardous Substances Data Bank and/or the NIOSH Pocket Guide to Chemical Hazards. The full 
Annex 1 list with the status of active substances under EU review can be downloaded as an Excel sheet at http://ec.europa.eu/food/plant/
protection/pesticides/index_en.print.htm.
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neurotoxicity. We used pesticide synonyms, commercial
names and the CAS number, in combination with each of
the terms "neurotoxic", "neurotoxicity", "neurologic",
"neurological" and "nervous system", and additional
searches included the terms "prenatal", "pregnancy",
"fetus", "fetal", "maternal", "developmental" and "child".
Organophosphate insecticides
Toxic mechanisms
The primary target of organophosphate (OP) insecticides
is the enzyme acetylcholinesterase (AChE), which hydro-
lyses the neurotransmitter acetylcholine in both the
peripheral and the central nervous system. OPs contain-
ing a P = O moiety are effective inhibitors of AChE,
whereas OPs with a P = S moiety require bioactivation to
form an "oxon" or oxygen analogue of the parent com-
pound. Inhibition of AChE by OPs is obtained by the P =
O moiety forming a covalent bond with the active site of
the enzyme. The enzyme-inhibitor complex can become
"aged" by a non-enzymatic hydrolysis of one of the two
radical groups in the OP, and once the complex has aged,
inhibition of AChE is irreversible (reviewed in [21]). Inhi-
bition of AChE causes accumulation of acetylcholine at
cholinergic synapses, leading to over-stimulation of mus-
carinic and nicotinic receptors. In addition, acetylcholine
has important functions during brain development [22].
In severe cases of OP poisoning in adults (AChE inhibi-
tion exceeding 70%) [23], a "cholinergic syndrome" is
elicited, including various central nervous system (CNS)
effects such as headache, drowsiness, dizziness, confu-
sion, blurred vision, slurred speech, ataxia, coma, convul-
sions and block of respiratory centre [24]. Some OPs can
also induce a delayed neuropathy which does not involve
inhibition of AChE but rather the neuropathy target este-
rase (NTE) [25,26]. The physiological functions of NTE
are still unknown, and it is obscure how phosphorylation
and aging of NTE leads to axonal degeneration [27].
The syndromes described above are observed only follow-
ing high dose, acute exposures to OPs. Survivors recover
from these syndromes, but it is likely that the exposure
also produces long-term adverse health effects. In rats, a
single high exposure to an OP can cause long lasting
behavioural effects [28,29], and the same has been
reported from several human studies (e.g. [30,31]).
The concern is growing that also chronic, low exposures to
OPs may produce neurological effects, although the evi-
dence remains somewhat equivocal (reviewed in [32-
34]). Most studies have found an association of OP expo-
sure with increased neurological symptom prevalence. As
an example, Hispanic immigrant farm workers in the US
have a poorer neurobehavioural performance than non-
agricultural Hispanic immigrants. Within the group of
agricultural workers there was a positive correlation
between urinary OP metabolite levels and poorer per-
formance on some neurobehavioural tests [35]. A cross-
sectional study of pesticide applicators reported that neu-
rological symptoms were associated with cumulative
exposure to moderate levels of organophosphate and
organochlorine insecticides, regardless of recent exposure
history [36].
Acetylcholine and other neurotransmitters play unique
trophic roles in the development of the CNS [37,38], and
inhibition of AChE by OPs and the resulting accumula-
tion of acetylcholine may then conceivably disturb this
development. Still, developing rats recover faster from
AChE inhibition than adults, largely due to the fact that
developing organisms have a rapid synthesis of new AChE
molecules [39-41]. It therefore seems that either develop-
mental toxicity may be unrelated to AChE inhibition, or
that even a brief period of AChE inhibition is sufficient to
disrupt development [42].
Chlorpyrifos is the most extensively studied OP with
respect to developmental neurotoxicity in laboratory
models. Prenatal or neonatal exposure has been shown to
cause a variety of behavioural abnormalities in both mice
and rats, including changes in locomotor skills and cogni-
tive performance [43-46]. At concentrations comparable
to those found in human meconium [47], experiments on
rat embryo cultures showed mitotic abnormalities and
evidence of apoptosis during the neural tube develop-
ment stage, and significant effects even at concentrations
more than an order of magnitude below those present in
human meconium [48]. However, exposure of rat foe-
tuses to chlorpyrifos by maternal administration did not
induce large immediate effects on brain development
[49], but chlorpyrifos treatment during gestation, did
cause deficits in brain cell numbers, neuritic projections,
and synaptic communication, which emerged in adoles-
cence and continued into adulthood. This finding indi-
cates that chlorpyrifos exposure during gestation results in
altered programming of synaptic development [50,51].
The window of vulnerability to chlorpyrifos extends into
relatively late stages of brain development, and chlorpyri-
fos can induce neurobehavioural abnormalities during
the second and third postnatal weeks in rat [43,52,53],
corresponding to the neonatal stage in humans [54]. This
period is outside the major phase of neurogenesis in most
brain regions, but it is the period of peak gliogenesis and
synaptogenesis; developing glia have been found to be
even more sensitive to chlorpyrifos than neurons [55-57].
Deficits elicited by prenatal exposure to chlorpyrifos are
evident even at exposures below the threshold for detect-
able AChE inhibition, i.e. far below the 70% inhibition of
Environmental Health 2008, 7:50 http://www.ehjournal.net/content/7/1/50
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AChE required for systemic toxicity in adults [43-46,51].
These findings suggest that mechanisms other than inhi-
bition of AChE activity may, at least in part, be responsi-
ble for the developmental neurotoxicity of chlorpyrifos.
The non-cholinergic mechanisms of chlorpyrifos are not
clear, but a possible target may be the signalling cascades
involved in neuronal and hormonal inputs, including the
cyclic-AMP – protein kinase A cascade, receptor signalling
through protein kinase C, and direct effects on the expres-
sion and function of nuclear transcription factors mediat-
ing the switch from proliferation to differentiation,
including c-fos, p53, AP-1, Sp1 and CREB (Ca2+/cAMP
response element binding protein) (reviewed in [42]).
The notion that chlorpyrifos may exert developmental
neurotoxicity through mechanisms other than inhibition
of AChE opens the possibility that OPs may have com-
pound specific effects that may be unrelated to the com-
mon AChE inhibitory effect. For example, microarray
analysis has shown that the two OPs, chlorpyrifos and
diazinon, have many similar effects on gene expression in
the neonatal rat brain, but also notable disparities. All of
the changes in gene expression induced by the two OPs
were observed with doses, which did not induce biologi-
cally significant AChE inhibition [58,59]. In neonatal rats,
diazinon and chlorpyrifos elicit each their unique pattern
of damage/repair and altered synaptic function, even
though OPs as a class target neural cell development and
ACh systems [60].
Thus, findings of OP induced developmental neurotoxic-
ity through individual mechanism other than the com-
mon AChE inhibition complicate extrapolation of effects
from one OP to another. The existence of clear effects of
OPs at doses below the threshold for AChE inhibition
clearly demonstrate that it is inadequate to use AChE
measurements alone as a biomarker for defining safe
exposure limits for developmental neurotoxicity of OPs
[60].
Epidemiologic evidence
With respect to developmental neurotoxicity of OPs in
humans, knowledge is still relatively sparse, and most
studies reflect exposures to more than one pesticide.
In California, USA, an association was found between
reflex abnormalities in neonates and increased concentra-
tions of OP metabolites measured in the mother's urine
during pregnancy [7]. In a follow-up of the same cohort,
urinary dialkyl phosphate metabolite levels during preg-
nancy, particularly from dimethyl phosphate pesticides,
were negatively associated with mental development in
the children at 24 months of age. No associations were
observed between neurodevelopment and metabolites
specific to malathion and chlorpyrifos [8].
In a cohort study of mothers and infants in New York City,
USA, maternal levels of chlorpyrifos above the limit of
detection, coupled with low maternal levels of paraoxo-
nase activity (an enzyme which hydrolyses certain OPs,
including chlorpyrifos oxon), were associated with
reduced head circumference in the infants [61]. In the
same cohort, prenatal levels of OP metabolites in the
mother's urine were associated with anomalies of primi-
tive reflexes in the infants [9].
In another New York City cohort, prenatal chlorpyrifos
exposures were found to be inversely associated with birth
weight and length [62]. In a follow up of this study, the
children's cognitive and motor development was exam-
ined at 1, 2 and 3 years of age. The adjusted mean 3-year
Psychomotor Development Index and Mental Develop-
ment Index scores of the highly exposed children differed
by 7.1 and 3.0 points, respectively, from the scores of chil-
dren with low prenatal exposure to chlorpyrifos. The pro-
portion of delayed children in the high-exposure group,
compared with the low-exposure group, was five times
greater for the Psychomotor Development Index and 2.4
times greater for the Mental Development Index [10].
Ecuadorian schoolchildren, whose mothers had been
exposed to OPs and other pesticides during pregnancy by
working in greenhouses, showed visuospatial deficits
compared to children, whose mothers had not been
exposed to pesticides during pregnancy. Furthermore, cur-
rent exposure of the children, measured as the excretion of
OP metabolites in urine, was found to be associated with
increased reaction time [11].
In two US states, Ohio and Mississippi, children were
acutely exposed to the OP, methyl parathion, and when
analysed for neurobehavioural development, the exposed
children were found to suffer from persistent problems
with short-term memory and attention [12].
Although the epidemiological evidence for developmen-
tal neurotoxicity of OPs in humans is relatively sparse,
there are clear indices of adverse effects. Urinary pesticide
metabolite levels in the above studies were similar to
those that have been recorded from the US general popu-
lation [3,63] and in EU countries [64-66].
Carbamate insecticides
Carbamate insecticides, like the OP insecticides, inhibit
AChE and elicit cholinergic hyperstimulation. However,
carbamates cause only reversible inhibition of AChE [67].
Thus, AChE inhibition by carbamates lasts only minutes
or hours, whereas the effects of OPs with respect to AChE
Environmental Health 2008, 7:50 http://www.ehjournal.net/content/7/1/50
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can last for 3–4 months (reviewed in [32]). Because of the
transient inhibition of AChE, acute intoxication by car-
bamates generally resolves within a few hours [67].
When comparing the clinical course of carbamate poison-
ing (by aldicarb or methomyl) in young children (1–8
years old) and adults (17–41 years old), it was found that
the predominant symptoms in children were CNS depres-
sion and hypotonia, and the most common muscarinic
effect was diarrhoea. In adults the main symptoms were
miosis and fasciculations, whereas CNS depression, hypo-
tonia, and diarrhoea were uncommon [68]. Symptoms in
children poisoned with OPs were found to be similar to
symptoms for carbamate poisoning [69]. Thus symptoms
of carbamate poisoning do not differ markedly from
symptoms of OP poisoning in children, but rather the
symptoms in children, differ from symptoms in adults.
It is possible that some carbamates may also be involved
in oxidative stress [70,71]. The carbamate, carbofuran, has
been observed to accentuate oxidative stress in rat brain
by inducing lipid peroxidation and diminishing the anti-
oxidant defence [70].
As for the OPs, it is likely that poisoning with carbamates
may result in long term neurological effects [72]. Two
patients showed cognitive deficit in attention, memory,
perceptual, and motor domains 12 months after a poison-
ing incident [72]. With respect to long term, low level
exposures to carbamates, reports concerning chronic tox-
icity are almost non-existent.
No epidemiological studies of developmental neurotoxic-
ity of carbamates in humans could be found, and data
from animal experiments are very sparse as well.
Assuming that some of the neurotoxic effects observed in
association with prenatal exposure to OPs, such as chlo-
rpyrifos, are due to inhibition of AChE, it is possible that
carbamates may have similar developmental effects, even
though the inhibition of AChE by carbamates is only tran-
sient. Induction of oxidative stress by some carbamates
might also cause developmental neurotoxicity. It should
also be noted that the carbamate physostigmine inhibits
DNA synthesis in undifferentiated neuronotypic PC12
cells (a standard in vitro model for neuronal develop-
ment). When differentiation was induced, adverse effects
on DNA synthesis were intensified, and effects on cell
number after prolonged exposure were also worsened by
differentiation. Furthermore, differentiating cells dis-
played signs of oxidative stress, as measured by lipid per-
oxidation. Finally, the transmitter fate of the cells was
shifted away from cholinergic phaenotype toward the cat-
echolaminergic phaenotype. Similar findings were made
when incubating the cells with the OPs chlorpyrifos,
diazinon and parathion [73].
Pyrethroid insecticides
The pyrethroids are a class of insecticides derived from
naturally occurring pyrethrins from the Chrysanthemum
genus of plants [74]. Pyrethroids contain several common
features: an acid moiety, a central ester, and an alcohol
moiety. Several stereoisomers exist of each pyrethroid
compound, and their effects are stereospecific, indicating
presence of specific binding sites (reviewed in [75]).
The acute toxicity of pyrethroids is mainly mediated by
prolongation of the kinetics of voltage-gated sodium
channels, which are responsible for generation of the
inward sodium current that produces the action potential
in excitable cells. Specific interaction of pyrethroids with
the sodium channel slows down both the activation and
inactivation properties of the channel, leading to a hyper-
excitable state. Although activation is slowed at the single
channel level, the density of sodium channels in excitable
cells is so high that there are always sufficient unmodified
channels to ensure that the activation phase of the action
potential is not delayed. However, in the falling phase of
the action potential, even a low proportion of modified
channels can generate enough extra current to delay inac-
tivation. This delay causes prolonged depolarisation,
which, if the current is large enough and lasts long enough
for neighbouring unmodified channels to recover excita-
bility, can trigger a second action potential (reviewed in
[76]).
Two types of pyrethroid structures exist. The type II pyre-
throids contain a cyano-group in the α-position, whereas
type I pyrethroids do not contain a cyano-group [77]. The
two types differ with respect to the toxic signs they pro-
duce in rats, and with respect to the prolongation time of
the sodium current they induce. Type I compounds pro-
long channel opening just long enough to induce repeti-
tive firing of action potentials (time constants less than 10
msec), whereas type II compounds (time constants of
more than 10 msec) hold the channels open for so long
that the membrane potential ultimately becomes depolar-
ised to the point at which generation of action potentials
is no longer possible (reviewed in [75]).
Human pyrethroid poisoning is rare, and almost entirely
involves type II pyrethroids. The main adverse effect of
dermal exposure to type II pyrethroids is paresthesias, pre-
sumably due to hyperactivity of cutaneous sensory nerve
fibres. Dizziness, headache and fatigue are common
symptoms following ingestion of type II pyrethroids. In
severe cases coma and convulsions are the principal life-
threatening features [77].
Environmental Health 2008, 7:50 http://www.ehjournal.net/content/7/1/50
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The effects of pyrethroids on the CNS are complex and
may also involve antagonism of γ-aminobutyric acid
(GABA), modulation of nicotinic cholinergic transmis-
sion, enhancement of noradrenalin release, and direct
actions on calcium or chloride ion channels. Still, because
neurotransmitter-specific pharmacological agents do not
protect very well against pyrethroid poisoning, it is
unlikely that any one of these effects represents a primary
toxic mechanism of action of pyrethroids. More likely,
they are secondary to the effects on sodium channels,
since most neurotransmitters are released secondary to
increased sodium entry (reviewed in [76]).
In the few existing accounts of poisonings of adults with
pyrethroids, successful recovery after the acute phase of
poisoning has been described [78,79]. However, no
detailed neuropsychological testing was applied to these
patients, and also no post mortem examinations have been
reported, and therefore it is unknown if such poisonings
may have lasting effects. Likewise, no information is avail-
able on long term effects of low level chronic exposure in
humans.
Neonatal rats are 4–17 times more vulnerable to the acute
toxicity of pyrethroids (including permethrin (type I), del-
tamethrin (type II), cypermethrin (type II)) than adult rats
[80,81]. The higher toxicity in neonates is affected by the
lower capacity for metabolic detoxification, since
neonates and adults have similar brain concentrations at
different, but equitoxic, doses [80]. However, another
study did not observe any age-dependency of the toxicity
of the two type I pyrethroids, cismethrin and permethrin
[82]. It has therefore been argued that age-dependent sen-
sitivity to pyrethroids is only apparent at high acute doses,
not at doses below those causing overt toxicity [82].
In addition to the possibility that young animals are more
vulnerable to pyrethroids due to lower metabolic detoxi-
fication, there is also a possibility that increased vulnera-
bility in young animals may be due to more specific
effects of early life exposures. For example, several studies
have found that embryonically expressed forms of volt-
age-gated sodium channels are replaced by adult forms as
neurodevelopment proceeds (reviewed in[75]), and this
difference in expression profile may affect the sensitivity
towards pyrethroids. In mutation and knockout models
of the voltage-gated sodium channels, perturbation of
channel function during development impairs nervous
system structure and function, underlining the impor-
tance of these channels in neurodevelopment. (reviewed
in [75]).
Also in humans, perturbations of nervous system develop-
ment have been associated with altered structure and
function of voltage-gated sodium channels. Mutations in
genes encoding sodium channel subunits have been iden-
tified, which result in neuronal hyperexcitability due to
subtle changes in channel gating and inactivation [83].
Since pyrethroids also alter the activation and inactivation
of sodium channels, and thereby the neuronal excitabil-
ity, it is possible that these may have effects similar to
mutations in the sodium channels. However, the mecha-
nisms and magnitude of mutational versus pyrethroid
effects are different, and also the duration of effect will dif-
fer (pyrethroids have a relatively short half-life, whereas
mutations are permanent) [75].
Another possible indication that pyrethroid effects on
sodium channels may be relevant to neurodevelopment is
the observation that developmental exposure to pheny-
toin, an anticonvulsant that blocks sodium channels and
other ion channels, disrupts nervous system structure and
function [84]. The use of anticonvulsants during preg-
nancy has been associated with adverse effects, including
microcephaly and intellectual impairment (reviewed in
[75]). Although differences in doses and in pathogenesis
may occur, this evidence would support a concern about
the effect of pyrethroids on ion channels.
All existing studies of developmental neurotoxicity of
pyrethroids were conducted with rodents as test animals,
and although several of them have reported persistent
changes in behaviour and/or neurochemistry in the ani-
mals, results appear somewhat inconsistent (reviewed in
[75]). Several studies performed by Eriksson's group [85-
87] have shown that mice exposed to pyrethroids on post-
natal day 10–16 exhibit increased motor activity and a
lack of habituation. These mice exhibit changes in density
of muscarinic acetylcholine receptor (mAChR) binding
for as long as 5 months after cessation of exposure [88].
Others have reported persistent changes in behaviour
and/or biochemistry, including learning [89], motor
activity [90], sexual behaviour [91], mAChR expression
[92,93], and blood-brain barrier permeability [94]. A
recent study in rats showed that neonatal exposure to per-
methrin and cypermethrin caused lasting behavioural
effects, changes in monoamine concentrations in the
striatum as well as increased oxidative stress [95]. In one
study, both male and female mice were exposed to the
type I pyrethroid, permethrin, before mating, and the fol-
lowing functions were affected in the offspring (with
parental exposure to 9.8 mg/kg/day or more for 4 weeks
before mating): development of reflexes, swimming abil-
ity and open field activity [96].
The potential developmental neurotoxicity of pyrethroids
has also been investigated in vitro using cell lines. For
example non-toxic concentrations (10-6 M) of bifenthrin
inhibited neurite outgrowth in PC12 cells, indicating that
bifenthrin may have deleterious effects on the developing
Environmental Health 2008, 7:50 http://www.ehjournal.net/content/7/1/50
Page 8 of 22
(page number not for citation purposes)
nervous system at concentrations lower than those capa-
ble of causing toxicity in the adult brain [97].
Existing data indicate that human exposures to pyre-
throids occur and result in detectable concentrations in
body fluids [98-100], but there is insufficient information
available to adequately evaluate the range of internal
doses in humans, and the consequences of these expo-
sures are so far unknown.
Dithiocarbamate fungicides
Dithiocarbamates are non-cholinesterase inhibiting, sul-
fur-containing carbamates, which are primarily used as
fungicides and herbicides. Four major classes of dithiocar-
bamates exist; the methyldithiocarbamates, the dimethyl-
dithiocarbamates, the diethyldithiocarbamates (DEDC),
and the ethylenebisdithiocarbamates (EBDCs) (reviewed
in [101]). The dithiocarbamates used as fungicides
include metam sodium (methyldithiocarbamate), thiram
(dimethyldithiocarbamate/tetramethyldithiocarbamate),
and several EBDCs (mancozeb, maneb, metiram, zineb
and nabam).
Dithiocarbamates form lipophilic complexes with di- and
trivalent metallic cations, bonding through the sulfur
atoms [102]. They are non-specific in action, and it is dif-
ficult to identify a single mechanism for their neurotoxic
effects. Because of their metal-chelating capacity and their
affinity for sulfhydryl groups, they are biologically highly
active [103,104]. DEDCs are particularly known to mod-
ify the cellular redox state by inducing a copper-depend-
ent oxidative stress [105,106], and inhibition of cytosolic
Cu/Zn superoxidedismutase (SOD1), a key enzyme in the
antioxidant response, has been observed in mice treated
with DEDC [107]. The EBDCs can uncouple the mito-
chondrial electron transport chain [108,109]. Mitochon-
drial dysfunction is often associated with generation of
reactive oxygen species (ROS), and ROS production was
also found to play a role in mancozeb induced neuronal
toxicity in mesencephalic cells, likely via redox cycling
with extracellular and intracellular oxidases [110]. Fur-
ther, ethylenethiourea (ETU), which is a degradation
product of EBDCs, has been shown to inhibit thyroid per-
oxidase (TPX), the enzyme that catalyses synthesis of the
thyroid hormones [111,112]. In addition, interference of
dithiocarbamates with the vesicular transport of gluta-
mate may play a role in their neurotoxicity [113]. Due to
the differences in biochemical effects, these compounds
seem to exhibit a range of different potencies in regard to
developmental neurotoxicity.
Dithiocarbamates are reported to display low acute toxic-
ity in humans and experimental animals [114]. Both in
humans and laboratory animals, prolonged exposure to
dithiocarbamates may cause neurotoxicity. Notably,
peripheral neuropathy and extrapyramidal symptoms
resembling parkinsonism have been associated with
chronic exposure to dithiocarbamate pesticides [115].
As mentioned, chronic exposure of humans to EBDCs has
been associated with neurocognitive impairment and par-
kinsonism [116]. In particular, exposure to maneb, which
contains manganese, has been linked to development of
parkinsonian-like symptoms in agricultural workers
[117,118]. This finding may be related to the inhibition of
complex III of the mitochondrial electron transport chain
[108], disruption of the glutathione antioxidant system in
dopaminergic cells [119], inhibition of proteasomal func-
tion and induction of α-synuclein aggregates in dopamin-
ergic cells [120], induction of catechol autooxidation
[121], and potentiation of the neurotoxicity of 1-methyl-
4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice
[122-124]. All of these observations support the notion
that maneb may cause parkinsonian-like symptoms.
DEDCs, though not methyldithiocarbamate, can also
enhance MPTP- induced striatal dopamine depletion in
mice [124].
Both thiram and ziram (dimethyldithiocarbamates) can
induce apoptotic cell death in PC12 cells, in a dose- and
time-dependent manner [125]. Both compounds induced
rapid and sustained increases of intracellular Ca2+ in the
cells, which were almost completely blocked by
flufenamic acid, an inhibitor of non-selective cation chan-
nels. Also, BAPTA-AM, which is an intracellular Ca2+ che-
lator, inhibited the thiram and ziram induced apoptotic
cell death, indicating that thiram and ziram induce apop-
totic neuronal cell death by Ca2+ influx through non-selec-
tive cation channels [125].
The EBDCs maneb, mancozeb and metiram can induce
malformations in rat foetuses, apparently mediated
through formation of the ETU metabolite. The malforma-
tions predominantly affect the nervous system and the
head, and they correspond to those expected as the result
of thyroid insufficiency. They occur only at doses in excess
of those that produce significant thyroid inhibition in
adult rats, and they have been prevented, at least in part,
by co-administration of thyroxin (reviewed in [126]). A
key concern with thyroid inhibitors is that impaired thy-
roid function may alter hormone-mediated events during
development, thereby possibly leading to permanent
alterations in brain morphology and function [127,128].
Functional deficits are likely to occur during brain devel-
opment even at mild degrees of hypothyroidism [129].
Even withing the normal range, a relatively slight reduc-
tion of the concentration of maternal thyroid hormones
during pregnancy can lead to intelligence deficits in the
children [130]. In addition to EBDCs/ETU, many other
environmental contaminants have been found to interfere
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with thyroid function, for example the chlorophenoxy
herbicide, 2,4-D (se below). Some of the mechanisms of
action with respect to thyroid inhibition are shared by
mancozeb/ETU and 2,4-D (including interference with
uptake of iodide by the thyroid gland and interference
with serum protein-bound iodide level) [131], and expo-
sure to both EBDCs and chlorophenoxy herbicides may
therefore result in additive effects.
Evidence that developmental exposure to maneb may be
involved in development of Parkinson's disease (PD) later
in life includes the finding that postnatal exposure of mice
to maneb in combination with paraquat (a classic bipyri-
dyl herbicide, which is no longer authorised in EU) led to
a permanent and selective loss of dopaminergic neurons
in the substantia nigra pars compacta [132]. The postnatal
exposure to these pesticides enhanced the effect of the
same pesticides administered during adulthood, relative
to exposures during development only or adulthood only.
Furthermore, exposure to maneb alone during gestation
resulted in a dramatic response to paraquat in adulthood,
including notable reductions in levels of dopamine and a
loss of nigral dopamine neurons. Thus, these results sup-
port the notion that a silent neurotoxicity produced by
developmental insults can be unmasked by insults later in
life [132].
For specific dithiocarbamates, especially the EBDCs
maneb and mancozeb, substantial evidence supports the
possibility of developmental neurotoxicity. In addition,
the likely mechanisms of toxicity for thiram and ziram
indicate that these compounds too may be capable of
causing developmental neurotoxicity in small doses.
Chlorophenoxy herbicides
The chlorophenoxy herbicides are widely used for the
control of broad-leaved weeds. Structurally, they consist
of a simple aliphatic carboxylic acid moiety, which is
attached to a chlorine- (or methyl-) substituted aromatic
ring by an ether bond. In vivo the salts and esters are rap-
idly dissociated or hydrolysed, and therefore the toxicity
of each chlorophenoxy compound depends principally
on the acid form of the pesticide [133]. The chlorophe-
noxy herbicides bind strongly to albumin [134], and
binding is favoured by longer acid chains and by more
greatly substituted aromatic rings. Therefore the bioavail-
ability and toxicity of the herbicides vary for different her-
bicides [135]. The mechanisms of neurotoxicity of the
chlorophenoxy herbicides are incompletely known, but
they seem to primarily involve cell membrane damage
(reviewed in [135]).
2,4-Dichlorophenoxyacetic acid (2,4-D) is the most
widely used chlorophenoxy herbicide and also the most
widely studied. With respect to membrane damage, it
does not cause significant penetration of lipid monolayers
in vitro at concentrations below 0,1 μM [134], but at
higher concentrations (10–100 μM) it increases bilayer
width and causes deep structural perturbations of the
hydrophobic region of model membrane systems. At the
higher concentrations it also damages human erythrocyte
cell membranes [136]. This dose- dependent effect on
plasma membranes may in part explain the dose-depend-
ent CNS toxicity caused by chlorophenoxy herbicides. In
experimental animals (rats, mice and rabbits), only small
amounts of herbicide were found in the brain following
administration of 100 mg/kg or less [137-139], likely
because low concentrations of herbicide have little effect
on the plasma membranes comprising the blood-brain
barrier. When exposing rats to high doses (250–500 mg/
kg) of the herbicide, a reversible selective damage to the
blood-brain barrier occurred, and as a result serum albu-
min and IgG could be detected in the brain along with the
herbicide itself [140]. The severity of the herbicide-
induced cerebrovascular damage in rats has been reported
to increase in the order 2,4,5-T (2,4,5-trichlorophenoxy-
acetic acid) < MCPA (4-chloro-2-methylphenoxyacetic
acid) < 2,4-D [141].
Chlorophenoxy herbicides can also disrupt cell mem-
brane transport mechanisms. They competitively inhibit
and ultimately saturate the organic anion transport sys-
tem in the choroid plexus, which facilitates the removal of
potentially toxic anions (including endogenous neuro-
transmitter metabolites and exogenous organic acids)
[139,142,143]. Homovanillic acid and 5-hydroxy-3-
indoleacetic acid, i.e. metabolites of dopamine and serot-
onin, respectively, accumulate in the CNS of rats follow-
ing 2,4-D administration [144].
It has also been reported that 2,4-D induced neurotoxicity
may be partly due to generation of free radicals. When
incubating rat cerebellar granule cells with 2,4-D in vitro,
glutathione (GSH) levels and catalase activity were signif-
icantly reduced, whereas generation of reactive oxygen
species (ROS) and activity of selenium-glutathione perox-
idase (Se-GPx) were augmented [145].
Furthermore, chlorophenoxy acids are structurally related
to acetic acid and are able to form analogues of acetyl-CoA
(e.g. 2,4-D-CoA) in vitro. Formation of such analogues has
the potential of disrupting several pathways involving
acetyl-CoA, including the synthesis of acetylcholine. Pos-
sible formation of choline esters (e.g. 2,4-D-Ach) may act
as false cholinergic messengers (reviewed in [135]).
In cerebellar granule cells, 2,4-D produced a striking and
dose-dependent inhibition of neurite extension, and in
vitro 2,4-D inhibited polymerisation of purified tubulin.
Thus, it was suggested that at least one mechanism of 2,4-
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D neurotoxicity involves inhibition of microtubule
assembly [146]. Yet another study with cerebellar granule
cells showed that 2,4-D induced apoptosis when cells
were exposed to millimolar concentrations of the com-
pound [147].
Chlorophenoxy herbicide poisoning in humans is
uncommon, but it may produce severe sequelae. In a
review of 66 cases of chlorophenoxy herbicide poisoning
[135], the majority of cases involved ingestion of 2,4-D,
either alone or in combination with other chlorophenoxy
herbicides. Neurotoxic effects included coma, hypertonia,
hyperreflexia, ataxia, nystagmus, miosis, hallucinations,
convulsions, fasciculations, and paralysis. Some degree of
peripheral neuromuscular involvement occurred in
approximately one third of the cases reviewed. Still, other
constituents, such as surfactants or solvents, in the formu-
lations of the herbicides could possibly have contributed
to some of the effects observed [135].
The information with respect to possible neurological
effects of chronic exposures to low doses of chlorophe-
noxy herbicides is sparse, and in a review from 2002, it
was concluded that it is unlikely that 2,4-D has any neu-
rotoxic potential at doses below those required to induce
systemic toxicity [148]. However, a cohort study suggested
an increased risk of amyotrophic lateral sclerosis (ALS)
among workers chronically exposed to 2,4-D, compared
to non-exposed employees at the same company,
although this conclusion was based on only three deaths
[149].
Although neurotoxicity in adults from low, chronic expo-
sures to chlorophenoxy herbicides has not been reported,
developmental exposure to low levels of these herbicides
may still pose a threat. One case of cephalic malforma-
tions and severe mental retardation has been observed in
an infant whose parents received prolonged exposure to
2,4-D via the dermal route from forest spraying [150].
Evidence of developmental neurotoxicity of chlorophe-
noxy herbicides, in particular 2,4-D, has also been
obtained from experimental animals. For example, exter-
nal treatment of fertilised hens' eggs with 2,4-dichloroph-
enoxyacetic butyl ester produced hypomyelination in the
chicks, and reductions in "myelin markers" (including
sulfatides, cerebrosides and 2'3'-cyclic nucleotide 3'-phos-
phohydrolase activity) were seen in chick embryos even
before the period of active myelination [151]. A deficit in
myelin lipid deposition was also detected in neonatal rats
exposed to 2,4-D through lactation [152]. Other findings
in response to neonatal exposure of rats to 2,4-D through
lactation include a delay in CNS development [153], an
increase in size and density of serotonin immunoreactive
neuronal somata as well as an increase in fibre length in
the dorsal and medial raphe nuclei [154]; and oxidative
stress in specific brain areas, including midbrain, stria-
tum, and prefrontal cortex [155].
Behavioural effects in the offspring have also been
reported following prenatal and continued exposure to
2,4-D [156]. Also following prenatal and continued expo-
sure of rats to 2,4-D, even beyond lactation, the dopamine
D2-type receptor was increased about 40% in the striatum.
Increased levels of the receptor were also found in the pre-
frontal cortex and cerebellum. However, when discontin-
uing exposure after weaning, no differences in dopamine
D2-type receptors could be detected compared to control
rats, suggesting that the effects of 2,4-D on these receptors
may be reversible [157].
Thus, even though the evidence is sparse, some chloroph-
enoxy herbicides, in particular 2,4-D, have neurotoxic
potentials and may cause developmental neurotoxicity.
Bipyridyl herbicides
The bipyridyl herbicides share common toxic mecha-
nisms [158,159]; paraquat has been used as a model sub-
stance, but is no longer allowed in the EU. Intracellularly,
both paraquat and diquat undergo redox cycling, leading
to the generation of superoxide anions. These anions may
react to form hydrogen peroxide and subsequently the
highly reactive hydroxyl radical, which may then cause
lipid peroxidation and cell death [159,160]. Another fac-
tor contributing to toxicity is the depletion of nicotina-
mide adenine dinucleotide phosphate with a bound
hydrogen ion (NADPH), as both herbicide redox cycling
and hydrogen peroxide detoxification via glutathione are
NADPH dependent [159,161]. In addition to redox-
cycling, there is some evidence that paraquat may be able
to interact with enzymatic targets in the CNS, such as
AChE and butylcholinesterase [162].
The initial phase of moderate to severe intoxication with
paraquat and diquat is characterised by renal and liver
failure, but the subsequent clinical course differs between
the two, with intestinal paralysis and fluid loss as promi-
nent features of diquat intoxication [160,163-165]. In
severe and usually fatal cases of diquat poisoning, coma
has also been reported [160]. Severe neurological and
neuropsychiatric complications due to brain stem infarc-
tion and/or intracranial haemorrhage have also been
described [161,163,166].
In regard to long-term consequences of exposure to bipy-
ridyl herbicides, paraquat is a prime suspect with respect
to induction of PD. It causes selective degeneration of
tyrosine hydroxylase immunopositive (TH+) neurons in
the substantia nigra pars compacta, and long-term expo-
sure has been found to increase the risk of PD in a Taiwan
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population that sprays paraquat on rice fields [167-169].
A case report has described PD following diquat exposure
[170], but because of a long induction period and the dif-
ficulties in retrospective exposure assessment, the hypoth-
esis of delayed appearance of degenerative nervous system
disease is difficult to verify. Since both paraquat and
diquat can generate the formation of ROS, these com-
pounds may well be involved in neurodegenerative dis-
eases other than PD, such as Alzheimer's disease, but little
evidence is available to evaluate this potential.
Even though it is rather clear that the cytotoxicity of
paraquat involves oxidative stress [171], the sensitivity of
dopaminergic neurons is difficult to explain [172]. Possi-
bly, the dopaminergic neurons may be particularly sensi-
tive to the reactive oxygen species (ROS) from paraquat,
since dopamine metabolism also creates ROS [173]. In
mice treated with paraquat once a week for 3 weeks, the
effect on catecholaminergic neurons was reminiscent of
that in PD, with a preferential loss of dopaminergic neu-
rons in the substantia nigra pars compacta. This is consist-
ent with the results from several similar studies
[168,169,171].
PD has also been explored as a relevant outcome with
respect to developmental neurotoxicity. When neonatal
mice were exposed to paraquat, a marked hypoactive con-
dition was apparent at 60 days of age and became even
more pronounced at 120 days of age [174]. Furthermore,
paraquat reduced the striatal content of dopamine and
metabolites without affecting serotonin [174]. As already
mentioned above under dithiocarbamates, other evidence
suggests that maneb and paraquat may jointly and indi-
vidually induce loss of dopaminergic neurons in mice.
Administration of these pesticides postnatally enhanced
the effect of the same pesticides administered during
adulthood. Furthermore, exposure to maneb alone during
gestation resulted in a dramatically increased response to
paraquat in adulthood, including notable reductions in
levels of dopamine and a loss of nigral dopamine neurons
[132]. Similarly, the greatest effect on locomotor activity
in mice occurred in males after exposure to maneb prena-
tally and to paraquat in adulthood [175]. This finding was
supported by decreased levels of striatal dopamine,
increased striatal dopamine turnover, and selective reduc-
tion in tyrosine hydroxylase-immunoreactive neurons of
the substantia nigra pars compacta.
These observations are in agreement with the notion that
an initially silent toxicity was later unmasked, and was
affected by the specific order-of-presentation of the pesti-
cides in regard to the developmental stage (not just an
effect of the combination of pesticides). Thus, it seems
that prenatal exposure to maneb, rather than paraquat,
may sensitise/predispose mice to development of PD (or
lead to a state of increased vulnerability), whereas
paraquat exposure later in life may unmask the silent toxic
effect of the earlier maneb exposure and then lead to clin-
ical symptoms of the disease. Therefore it is possible that
in the case of PD, developmental exposure to paraquat
may not be as damaging as later exposure, particularly if
this later exposure follows developmental exposure to
maneb.
Fumigants
The mechanisms of toxicity employed by various types of
fumigants are poorly known. A common mechanism of
action is not expected, and the fumigants are therefore
reviewed one by one.
Among metal phosphide fumigants, aluminium phos-
phide is one of the most extensively used. The phosphides
are very toxic, because of their ability to liberate phos-
phine under moist conditions (reviewed in [176]). Phos-
phine is a reductant and predictably reacts with metal ions
such as the iron in haem and the divalent metals of metal
dependent enzymes [177]. Cytochrome c oxidase, of the
mitochondrial electron transport chain, has been sug-
gested as the primary site of action for phosphine
[176,178,179]. A 50% inhibition of this enzyme was
found to be sufficient for generation of superoxide anions,
and it was suggested that the toxicity of phosphine was
due to damage by free radicals [178]. In agreement with
this hypothesis, aluminium phosphide has been found to
increase lipid peroxidation in rat brain [180].
Further, in 45 phosphine poisoning patients, increased
levels of superoxide dismutase (SOD) and malondialde-
hyde (MDA) were detected in non-survivors, while cata-
lase was inhibited [181]. Oxidation of phosphine can lead
to formation of reactive phosphorylating species [182],
thus suggesting that effects on cholinesterase may be pos-
sible [183]. Studies of grain fumigant applicators [184]
and in vitro studies of human red blood cells [185] have
shown that significant phosphine-induced inhibition of
red blood cell cholinesterase occurs at concentrations of
phosphine exceeding 10 μg/ml.
Neurological changes like ataxia, stupor, tremors and con-
vulsions have been observed following aluminium phos-
phide poisoning. Acute hypoxic encephalopathy has also
been observed following aluminium phosphide poison-
ing, which may lead to death as a result of complete
depression of the central nervous system and paralysis of
the respiratory centres of the brain (reviewed in [176]).
With respect to consequences of chronic phosphide expo-
sure knowledge is sparse, but one descriptive study
reported that most of a group of workers exposed to zinc
phosphide had one or more neuropsychiatric symptoms
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including anxiety, impotence and easy fatigue. About half
of the workers showed hyperreflexia, polyneuropathy,
lumbar radiculopathy, and cervical myelopathy, as well as
anxious mood, impaired attention, and psychomotor
stimulation. EEG recordings showed abnormal findings
in 17.4% of the subjects, mainly those with longer expo-
sure [186]. These preliminary findings should invite fur-
ther studies in this area.
For the fumigant sulfuryl fluoride, very little is known
concerning the mechanism of toxicity. The fluoride ion
may play a role, since many of the observations in rodents
overexposed to sulfuryl fluoride are typical of acute fluo-
ride poisoning [187]. In humans, short-term inhalation
exposure to high concentrations of sulfuryl fluoride has
been reported to cause central nervous system effects
[188]. A case report describes an elderly couple, who
returned to their home 5–8 hours after fumigation with
sulfuryl fluoride. The wife experienced weakness, nausea,
and repeated vomiting, while the husband complained of
dyspnea and restlessness. Within 48 hours the husband
had a generalised seizure followed by cardiopulmonary
arrest. The wife died within 7 days due to ventricular
fibrillation. The serum fluoride concentration of the wife
six days after the fumigation was reported to be as high as
0.5 mg/L [189].
Workers with a chronic, low level exposure to sulfuryl flu-
oride showed non-significantly reduced performance on
all applied neurobehavioural tests compared to the con-
trol group in one study [190]. Education levels, ethnicity
and drug use differed between the workers and the control
group in this study. In a later study of structural fumiga-
tion workers [191], sulfuryl fluoride exposure during the
year preceding the examination was associated with sig-
nificantly reduced performance on the Pattern Memory
Test (a test of cognitive and visual memory) and an olfac-
tory test. No pattern of cognitive deficits was detected.
None of these fumigants has been examined in detail for
possible developmental neurotoxicity. Pregnant rats and
rabbits exposed to sulfuryl fluoride were reported to show
no evidence of embryotoxicity, foetotoxicity, or tera-
togenicity at concentrations of sulfuryl fluoride as high as
225 ppm, although body weights of rabbit foetuses as well
as the dams at the highest exposure were lower than in the
control group [192].
In regard to phosphine, a large epidemiological study
found that adverse neurological and neurobehavioural
developmental effects clustered among children fathered
by applicators of phosphine (odds ratio = 2,48; 95% con-
fidence interval: 1.2, 5.1) [193]. Other than this study, no
information regarding developmental neurotoxicity of
phosphine was identified.
Other pesticides
The present review on neurotoxicity has focused on a
small number of substances out of the total number
approved for use as pesticides in the EU. Quite likely,
much evidence exists on neurotoxicity, but has not been
published in biomedical journals. Nicotine, warfarin and
ethanol are additional well documented neurotoxicants,
but their primary use is not as pesticides. The same applies
to other substances listed, such as sodium hypochlorite
and aluminium sulfate, which may potentially add to
neurotoxic hazards.
Public health implications
Some of the substances belonging to the groups of pesti-
cides reviewed here (including OPs, carbamates, pyre-
throids, ethylenebisdithiocarbamates, chlorophenoxy
herbicides, and bipyridyl herbicides) appear to share com-
mon mechanisms of action with respect to induction of
neurotoxicity. Thus, members of these chemical groups of
pesticides other than those identified as neurotoxic in the
present review, would then be highly likely also to cause
neurotoxicity. For other groups of pesticides without a
plausible common mechanism of action (e.g. the fumi-
gants), it is not possible to predict whether group mem-
bers might share neurotoxicity potentials.
Further refinement of this prediction is difficult. As antic-
ipated, the literature on developmental neurotoxicity is
sparse for most of the pesticides. However, some evidence
does exist to suggest that several of the neurotoxic pesti-
cides in current use in the EU may cause developmental
neurotoxicity in small doses. Table 2 summarises the
existing evidence of developmental neurotoxicity for
groups of pesticides with common mechanisms of action.
Most evidence is available for the OPs, especially chlorpy-
rifos. The evidence strongly supports the notion that
developmental neurotoxicity may be induced by very low
exposure levels, i.e. much below those causing any neuro-
toxicity in adults. Most evidence still comes from studies
in laboratory animals, but some epidemiological data are
highly suggestive of neurotoxic effects caused by develop-
mental exposure of humans to OPs (including chlorpyri-
fos). In the case of OPs, which share inhibition of AChE
as a common mechanism of action in high doses, chlorpy-
rifos may employ other mechanisms of action at lower
doses associated with developmental neurotoxicity. In
fact developmental neurotoxicity in mice and rats can be
induced at doses, which cause no detectable inhibition
AChE [43-46,51]. Thus, even though a group of pesticides
shares a common mechanism of action at larger doses, it
cannot be excluded that compound specific mechanisms
may also exist at lower doses. This fact unfortunately com-
plicates the extrapolation of developmental neurotoxicity
from one member of a group of pesticides to another.
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Table 2: Evidence of developmental neurotoxicity caused by pesticides belonging to groups with likely common mechanisms of neurotoxicity
Group of pesticides (n)* Mechanism of neurotoxicity Developmental neurotoxicity 
reported in humans
References Developmental neurotoxicity 
reported in animals
References
Organophosphates (8) Inhibition of AChE (+ interference 
with signaling cascades at low doses)
Reflex abnormalities in neonates + 
affected mental development
[7,8] Altered programming of synaptic 
development in rats (Chlorpyrifos)
[50,51]
Reduced head circumference in 
infants + anomalies in primitive 
reflexes (Chlorpyrifos)
[61,9] Behavioural abnormalities including 
changes in locomotor skills and 
cognitive performance in rats and 
mice (Chlorpyrifos)
[43-46]
Reduced birth weight and length + 
developmental delay at 3 years of 
age (Chlorpyrifos)
[62,10]
Visuospatial deficits (prenatal 
exposure) + increased reaction time 
(current exposure in children)
[11]
Reduced short term memory and 
attention (Methyl parathion)
[12]
Carbamates (5) Inhibition of AChE 
(+ oxidative stress)
No reports were found No reports were found
Pyrethroids (7) Prolongation of kinetics of voltage-
gated sodium channels
Increased motor activity, lack of 
habituation, changes in mAChR 
density in mice
[85-88]
Learning changes in rats [89]
Changes in motor activity in rats [90]
Changes in sexual behaviour and 
higher activity of the dopaminergic 
system in rats
[91]
Changes in mAChR expression in 
rats
[92,93]
Changes in blood-brain permeability 
in rats
[94]
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Affected development of reflexes, 
swimming ability, open field activity in 
mice 
(parental exposure prior to mating)
[96]
Dithiocarbamates (EBDCs) 
(6)
Generation of ROS (metal chelating 
capacity, uncoupling of mitochondrial 
electron transport chain)
The EBDC metabolite, ETU, inhibits 
thyroid peroxidase 
(synthesis of thyroid hormones)
Maneb (in combination with 
paraquat) induces loss of 
dopaminergic neurons in substantia 
nigra pars compacta in mice
[132]
The metabolite of EBDCs, ETU, 
induces malformations of the nervous 
system (corresponding to thyroid 
insufficiency) in rats
Reviewed in [126]
Chlorophenoxy herbicides 
(11)
Not completely known: includes 
membrane damage, generation of 
free radicals, perhaps uncoupling of 
oxidative phosphorylation
A case of cephalic malformations 
and severe mental retardation in 
infant whose parents were heavily 
exposed to 2,4-D
[150] Hypomyelination in chicks
(2,4-D)
[151]
Deficit in myelin lipid deposition in 
rats
(2,4-D)
[152]
Delayed CNS development in rats
(2,4-D)
[153]
Increased size and densitiy of 
serotonin-reactive neuronal somata 
and increased fiber length in dorsal 
and medial raphe nuclei in rats
(2,4-D)
[154]
Oxidative stress in specific brain 
areas (midbrain, striatum, prefrontal 
cortex) in rats
(2,4-D)
[155]
Behavioural effects in rats including 
delay of righting reflex, negative 
geotaxis + motor abnormalities, 
excessive grooming and vertical head 
movements, hyperactivity
(2,4-D)
[156]
Table 2: Evidence of developmental neurotoxicity caused by pesticides belonging to groups with likely common mechanisms of neurotoxicity (Continued)
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Bipyridyl herbicides (1) Induction of oxidative stress Involvement of developmental 
exposure to paraquat in later 
development of PD like features in 
mice
[174]
Paraquat (in combination with 
maneb) induces loss of dopaminergic 
neurons in substantia nigra pars 
compacta in mice
[132]
*The number in parenthesis is the total number of pesticides from each group currently authorised for use in the EU as of August 2008. Only major evidence on developmental neurotoxicity in 
humans or in laboratory animals has been included.
Table 2: Evidence of developmental neurotoxicity caused by pesticides belonging to groups with likely common mechanisms of neurotoxicity (Continued)
Environmental Health 2008, 7:50 http://www.ehjournal.net/content/7/1/50
Page 16 of 22
(page number not for citation purposes)
However, the combined human evidence on develop-
mental neurotoxicity associated with OP exposure cannot
be ascribed to chlorpyrifos alone.
Other than for OPs, the evidence of developmental neu-
rotoxicity in humans is sparse, but evidence on develop-
mental neurotoxicity in laboratory animals exists for
pyrethroids, ethylenebisdithiocarbamates, and chloroph-
enoxy herbicides (mainly 2,4-D).
In the case of dithiocarbamates, evidence from laboratory
animals suggests that developmental exposure to, e.g.
maneb, may predispose the individual to development of
PD later in life in response to another exposure, in partic-
ular paraquat. Other experimental studies suggest that
prenatal exposure to paraquat can also predispose to
development of PD later in life. It seems that the greatest
effect of paraquat with respect to induction of PD is
obtained from exposure later in life, following early prim-
ing exposure to maneb [175]. Although PD is a degenera-
tive disease associated with aging, these data suggest that
developmental exposure to pesticides (e.g. maneb) may
constitute an aetiological factor that sensitises the individ-
ual to later insults (e.g. subsequent pesticide exposure,
and aging).
For the remaining pesticides that belong to groups with-
out a common mechanism of toxicity, the lack of research
on developmental neurotoxicity complicates the evalua-
tion of their safety. In a few cases (e.g. the fumigant sulfu-
ryl fluoride), the existing evidence from animal
experiments indicates that developmental neurotoxicity
may be unlikely to occur at doses below those causing
maternal toxicity [192,194]. Still, in these experiments,
possible later emerging effects or sensitisation caused by
developmental exposure has not been studied, so any
conclusion in this regard would be tentative.
On the other hand, with respect to the metal phosphide
fumigants, which release phosphine under moist condi-
tions, some evidence of developmental neurotoxicity does
exist. An epidemiologic study has found adverse neuro-
logical and neurodevelopmental effects among children
fathered by applicators of phosphine [193]. For the
remaining pesticides reviewed, no data from either
human or animal studies could be located by our search.
This review has focused on those pesticides, for which
human neurotoxicity has been reported in relation to spe-
cific exposures to the particular pesticide. This means that
we have excluded poisoning cases involving more than
one compound, where the contribution by each substance
may be unknown. Thus, our list of neurotoxic pesticides is
likely a substantial underestimate of the true number of
neurotoxic pesticides. The fact that no poisoning incident
with neurotoxic effects has been reported for a given pes-
ticide is of course no guarantee that the pesticide is not
neurotoxic, especially in regard to developmental expo-
sure. A prudent evaluation of the evidence would there-
fore suggest that, if individual members of a chemical
grouping of pesticides have been documented as neuro-
toxic, then all members of that group should be consid-
ered to be neurotoxic as well.
In addition to the problem of scarce – in many cases even
non-existing – scientific evidence on developmental neu-
rotoxicity of the pesticides in current use, some discrepan-
cies exist between results of animal studies. An important
factor in regard to apparent discrepancies is that the tim-
ing of exposure varies between studies. In some studies,
animals are exposed prenatally, in other studies neona-
tally (during the first weeks of life), and in some studies
both prenatally and neonatally. The timing of exposure
may greatly influence the extent and type of neurotoxicity
induced. Most animal studies have been performed in
rodents, where brain development is mainly neonatal and
spans the first three to four weeks of postnatal life
[14,195]. Thus, although neurotoxic effects may be
induced in rodents by only prenatal exposure, it is highly
likely that these studies underestimate the neurotoxic
effects, which may occur in response to prenatal exposure
of humans, where the third trimester of pregnancy is a cru-
cial period of brain development.
A further concern is that humans are very likely to be
exposed to a number of pesticides and other neurotoxic
compounds simultaneously. Because it is possible that
some of these may have synergistic or additive effects,
exposure to even very low doses during development may
cause neurotoxic damage.
In addition to "direct" neurotoxicity, there is also evidence
that several pesticides may indirectly cause neurotoxicity,
e.g. by interference with thyroid function. Some 60% of
all herbicides, in particular 2,4-D, acetochlor, aminotria-
zole, amitrole, bromoxynil, pendamethalin, and thiou-
reas have been reported to interfere with thyroid function
(reviewed in[196]). In addition, EBDC dithiocarbamates,
organophosphates and synthetic pyrethroids are thought
to interfere with thyroid function (reviewed in [197]). A
key concern with thyroid inhibitors is that impaired thy-
roid function may alter hormone-mediated events during
development, leading to permanent alterations in brain
morphology and function [127,128]. Other types of
endocrine disruption can conceivably lead to neurobe-
havioural deficits, but this evidence has not been included
here.
The current evidence can therefore be summed up as fol-
lows. A substantial proportion of pesticides in current use
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are known to be neurotoxic. However, neurotoxicity
potentials of pesticides have not necessarily been exam-
ined, as legally mandated tests do not require specific
assessment of neurotoxic potentials, apart from tests for
peripheral neurotoxicity in hens required for OPs. A test
battery for developmental neurotoxicity has only recently
been completed by OECD, and very limited test data are
available for pesticides. Because developmental neurotox-
icity can occur at exposures much below those that cause
toxicity to the adult brain, usage restrictions and legal lim-
its for pesticide residues in food may not be sufficiently
protective against developmental neurotoxicity. In addi-
tion, experimental, clinical and epidemiologic evidence
supports the notion that neurotoxicity may be much more
severe and possibly irreversible when the exposure occurs
during early development.
Unless documentation exists for a particular pesticide to
falsify this notion, all neurotoxic pesticides should be
considered likely of inducing developmental neurotoxic-
ity at low doses. The public health significance of this
issue is illustrated by the epidemiologic observation of
neurodevelopmental deficits at exposure levels that seem
to be commonly occurring in the general population.
Although the exact identity of the causative substances
may be uncertain, pesticide contamination of foods is
common in the EU, it often exceeds previously identified
legal limits, and it involves substances that are known to
be neurotoxic. Given the substantial impact of neurode-
velopmental abnormalities in society and the likely
impact of environmental aetiologies, prevention of pesti-
cide exposure appears to be an obvious public health pri-
ority.
Conclusion
Given the widespread use and exposure to pesticides, the
general lack of data on developmental neurotoxicity is a
serious impediment. For certain pesticides, a requirement
exists for neurotoxicity tests in adult animals, but develop-
mental neurotoxicity is usually not considered when
determining pesticide safety. Experimental, clinical, and
epidemiologic evidence suggests that neurotoxic pesti-
cides can also cause developmental neurotoxicity, and
that the effects are more severe and lasting, and that they
occur at much lower exposure levels. Some of this evi-
dence relates to model substances that have now been
banned or restricted, but currently used substances with
similar mechanisms of toxicity should be regarded to
share the same toxic potentials. Thus, many widely used
pesticides, such as organophosphates, carbamates, pyre-
throids, ethylenebisdithiocarbamates, and chlorophe-
noxy herbicides should be considered
neurodevelopmental toxicants, unless convincing evi-
dence exists for individual substances that they deviate
from the general group characteristics. Given the likely
environmental aetiology of neurodevelopmental deficits
and their importance to families and to society, preven-
tion of exposures to neurotoxic pesticides should be made
a public health priority. Existing uncertainties should not
be used as an excuse for rejecting precautionary action.
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